WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Croatia ruling conservatives will form government with a farFather's grief after boy, 14, with 'no concept of danger' is found dead in river after vanishingPanera will stop serving 'Charged Sips' drinks after wrongful death lawsuitsMaradona’s missing trophy has resurfaced and will be auctioned in ParisStock market today: Asian shares mixed after calm day on Wall StTikToker reveals the 'dystopian hack' that snuck her résumé past AI bots and landed her three jobsAnother tennis player suspended for corruption linked to matchAnother tennis player suspended for corruption linked to matchFormer Daytona 500 winner McDowell will leave Front Row Motorsports for Spire in 2025Kings of the mountain: Joining a team of 20 St Bernards